Bioelectrical phase angle and psoriasis: A novel association with psoriasis severity, quality of life and metabolic syndrome

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Barrea, Luigi ^a   Macchia, Paolo Emidio ^b   Di Somma, Carolina ^c   Napolitano, Maddalena ^b   Balato, Anna ^b   Falco, Andrea ^a   Savanelli, Maria Cristina ^a   Balato, Nicola ^b   Colao, Annamaria ^b   Savastano, Silvia ^b  

^a IOS and COLEMAN Srl   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Dermatology life quality index (DLQI); Environmental factors; Metabolic syndrome (MetS); Phase angle (PhA); Psoriasis area and severity index (PASI) score

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ANTHROPOMETRY; ARTICLE; BIOELECTRICAL IMPEDANCE ANALYSIS; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DERMATOLOGY LIFE QUALITY INDEX; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBSERVATIONAL STUDY; PHASE ANGLE; PREVALENCE; PROGNOSIS; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; QUALITY OF LIFE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; BIOMECHANICS; COMPLICATION; IMPEDANCE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RISK FACTOR; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADULT; AGED; BIOMECHANICAL PHENOMENA; CASE-CONTROL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PSORIASIS; QUALITY OF LIFE; REGRESSION ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84986285561     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0889-6     Document Type: Article

References (49)

1. Grozdev I, Korman N, Tsankov N. Psoriasis as a systemic disease. Clin Dermatol. 2014;32:343-50.
2. Balato N, Balato A, Gallo L, Napolitano M, Patruno C, Ayala F. Psoriasis and osteoporosis: data from a Southern Italian population. Arch Osteoporos. 2012;7:321-3.
3. Gremese E, Tolusso B, Gigante MR, Ferraccioli G. Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases). Front Immunol. 2014;11:5-576.
4. Gisondi P, Galvan A, Idolazzi L, Girolomoni G. Management of moderate to severe psoriasis in patients with metabolic comorbidities. Front Med. 2015;2:1.
5. Balato N, Napolitano M, Ayala F, Patruno C, Megna M, Tarantino G. Nonalcoholic fatty liver disease, spleen and psoriasis: new aspects of low-grade chronic inflammation. World J Gastroenterol. 2015;22:6892-7.
6. Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6(2):109-20.
7. Ganzetti G, Campanati A, Molinelli E, Offidani A. Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: three different diseases on a unique background. World J Cardiol. 2016;8(2):120-31.
8. Shahwan KT, Kimball AB. Psoriasis and cardiovascular disease. Med Clin North Am. 2015;99(6):1227-42.
9. Toussirot E, Aubin F, Dumoulin G. Relationships between adipose tissue and psoriasis, with or without arthritis. Front Immunol. 2014;12:5-368.
10. Engin B, Kutlubay Z, Yardimci G, Vehid HE, Ambarcioglu P, Serdaroglu S, Tüzün Y. Evaluation of body composition parameters in patients with psoriasis. Int J Dermatol. 2014;53(12):1468-73.
11. Barrea L, Balato N, Di Somma C, Macchia PE, Napolitano M, Savanelli MC, Esposito K, Colao A, Savastano S. Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? J Transl Med. 2015;27:13-8.
12. Di Renzo L, Bianchi A, Saraceno R, Calabrese V, Cornelius C, Iacopino L, Chimenti S, De Lorenzo A. 174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-a blockers. Pharmacogenet Genomics. 2012;22(2):134-42.
13. Xu Y, Xie X, Duan Y, Wang L, Cheng Z, Cheng JA. Review of impedance measurements of whole cells. Biosens Bioelectron. 2016;15(77):824-36.
14. Barbosa-Silva MC, Barros AJ, Wang J, Heymsfield SB, Pierson RN Jr. Bioelectrical impedance analysis: population reference values for phase angle by age and sex. Am J Clin Nutr. 2005;82(1):49-52.
15. Bosy-Westphal A, Danielzik S, Dorhofer RP, et al. Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and body mass index. JPEN J Parenter Enteral Nutr. 2006;30:309-16.
16. Marini E, Buffa R, Saragat B, Coin A, Toffanello ED, Berton L, Manzato E, Sergi G. The potential of classic and specific bioelectrical impedance vector analysis for the assessment of sarcopenia and sarcopenic obesity. Clin Interv Aging. 2012;7:585-91.
17. Kyle UG, Soundar EP, Genton L, Pichard C. Can phase angle determined by bioelectrical impedance analysis assess nutritional risk? A comparison between healthy and hospitalized subjects. Clin Nutr. 2012;31:875-81.
18. Norman K, Stobäus N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis-clinical relevance and applicability of impedance parameters. Clin Nutr. 2012;31(6):854-61.
19. Stobäus N, Pirlich M, Valentini L, Schulzke JD, Norman K. Determinants of bioelectrical phase angle in disease. Br J Nutr. 2012;107(8):1217-20.
20. Norman K, Stobäus N, Zocher D, Bosy-Westphal A, Szramek A, Scheufele R, Smoliner C, Pirlich M. Cutoff percentiles of bioelectrical phase angle predict functionality, quality of life, and mortality in patients with cancer. Am J Clin Nutr. 2010;92(3):612-9.
21. Dittmar M, Reber H, Kahaly GJ. Bioimpedance phase angle indicates catabolism in type 2 diabetes. Diabet Med. 2015;32(9):1177-85.
22. de Luis DA, Aller R, Romero E, Dueñas A, Perez Castrillon JL. Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients. Eur Rev Med Pharmacol Sci. 2010;14(6):521-6.
23. Spuls PI, Lecluse LL, Poulsen ML, Bos JD, Stern RS, Nijsten T. How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. J Invest Dermatol. 2010;130:933-43.
24. Harari M, Shani J, Hristakieva E, Stanimirovic A, Seidl W, Burdo A. Clinical evaluation of a more rapid and sensitive psoriasis assessment severity score (PASS), and its comparison with the classic method of psoriasis area and severity index (PASI), before and after climatotherapy at the Dead-Sea. Int J Dermatol. 2000;39:913-8.
25. Finlay AY, Khan GK. Dermatology life quality index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-6.
26. Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA. 2001;285(19):2486-97.
27. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl 1):S11-63.
28. [No authors listed]. Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology Assessment Conference Statement. Am J Clin Nutr. 1996;64:524S-32S.
29. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gómez J, Lilienthal Heitmann B, Kent-Smith L, Melchior JC, Pirlich M, Scharfetter H, Schols AMWJ, Pichard C, ESPEN. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430-53.
30. Marra M, Pasanisi F, Scalfi L. The prediction of basal metabolic rate in young adult, severely obese patients using single frequency bioimpedance analysis. Acta Diabetol. 2003;40:s139-42.
31. Belfiore A, Cataldi M, Minichini L, Aiello ML, Trio R, Rossetti G, Guida B. Short term changes in body composition and response to micronutrient supplementation after laparoscopic sleeve gastrectomy. Obes Surg. 2015;25(12):2344-51.
32. Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance phase angle and body composition. Am J Clin Nutr. 1988;48:16-23.
33. Schwenk A, Beisenherz A, Römer K, Kremer G, Salzberger B, Elia M. Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment. Am J Clin Nutr. 2000;72:496-501.
34. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int. 1994;46:534-9.
35. Chertow GM, Lowrie EG, Wilmore DW, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995;6:75-81.
36. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM. Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr. 2003;77(4):842-6.
37. Di Mauro M, Lazzarini D, Fumelli P, Carle F, Kosmidis A. Bioelectrical impedance analysis and diabetes mellitus: which correlation among fructosamine, glycosylated haemoglobin and exchangeable potassium. Minerva Med. 2007;98(6):633-8.
38. Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. 2014;16:7-17.
39. Buscemi S, Blunda G, Maneri R, Verga S. Bioelectrical characteristics of type 1 and type 2 diabetic subjects with reference to body water compartments. Acta Diabetol. 1998;35(4):220-3.
40. Malkic Salihbegovic E, Hadzigrahic N, Cickusic AJ. Psoriasis and metabolic syndrome. Med Arch. 2015;69(2):85-7.
41. Selberg O, Selberg D. Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol. 2002;86(6):509-16.
42. Wirth R, Volkert D, Rösler A, Sieber CC, Bauer JM. Bioelectric impedance phase angle is associated with hospital mortality of geriatric patients. Arch Gerontol Geriatr. 2010;51(3):290-4.
43. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M. European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing. 2010;39(4):412-23.
44. Rizzoli R, Reginster JY, Arnal JF, Bautmans I, Beaudart C, Bischoff-Ferrari H, Biver E, Boonen S, Brandi ML, Chines A, Cooper C, Epstein S, Fielding RA, Goodpaster B, Kanis JA, Kaufman JM, Laslop A, Malafarina V, Mañas LR, Mitlak BH, Oreffo RO, Petermans J, Reid K, Rolland Y, Sayer AA, Tsouderos Y, Visser M, Bruyère O. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93(2):101-20.
45. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, van Kan GA, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249-56.
46. Beenakker KG, Ling CH, Meskers CG, de Craen AJ, Stijnen T, Westendorp RG, Maier AB. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res Rev. 2010;9(4):431-6.
47. Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature. 2007;445(7130):866-73.
48. Basile C, Della-Morte D, Cacciatore F, Gargiulo G, Galizia G, Roselli M, Curcio F, Bonaduce D, Abete P. Phase angle as bioelectrical marker to identify elderly patients at risk of sarcopenia. Exp Gerontol. 2014;58:43-6.
49. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis. 2012;6(6):665-73.